Noninvasive prenatal testing by maternal plasma DNA analysis: Current practice and future applications

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 74, Issue SUPPL. 244, 2014, Pages 48-53

  Chiu, Rossa W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Down syndrome; Maternal plasma DNA; Noninvasive prenatal diagnosis

Indexed keywords

DNA;

BLOOD SAMPLING; CONFERENCE PAPER; DNA CONTENT; DNA DETERMINATION; DNA METHYLATION; DOWN SYNDROME; FEMALE; FETUS CIRCULATION; HAPLOTYPE; HUMAN; KARYOTYPE; KARYOTYPING; MASSIVELY PARALLEL SEQUENCING; MATERNAL PLASMA; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNAROUND TIME; ANEUPLOIDY; BLOOD; MASS SCREENING; PREGNANCY; SENSITIVITY AND SPECIFICITY;

ANEUPLOIDY; DNA; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84905368718     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2014.936681     Document Type: Conference Paper

References (30)

1. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-7.
2. Lo YMD, Chiu RWK. Genomic analysis of fetal nucleic acids in maternal blood. Annu Rev Genomics Hum Genet 2012; 13: 285-306.
3. Antonarakis SE, Lyle R, Dermitzakis ET, et al. Chromosome 21 and Down syndrome: from genomics to pathophys-iology. Nat Rev Genet 2004; 5: 725-38.
4. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001-11.
5. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008; 105: 20458-63.
6. Chiu RWK, Sun H, Akolekar R, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010; 56: 459-63.
7. Chiu RWK, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342: c7401.
8. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13: 913-20.
9. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119: 890-901.
10. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 207: 137 e1-8.
11. Chen EZ, Chiu RWK, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011; 6: e21791.
12. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012; 14: 296-305.
13. Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013; 92: 167-76.
14. Yu SCYJ, Jiang P, Choy KW, et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One 2013; 8: e60968.
15. NCHPEG and NSGC. Non-invasive prenatal testing (NIPT): Factsheet 2012. Accessed 3 June 2014 from: http://www.nchpeg.org/index.php?option = comcontent & view = article & id = 384 & Itemid = 255
16. Noninvasive prenatal testing for fetal aneuploidy. Committee opinion No. 545: American College of Obstetrics and Gynecology, 2012.
17. Benn P, Borell A, Chiu R, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013; 33: 622-9.
18. Langlois S, Brock JA, Wilson RD, et al. Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can 2013; 35: 177-81.
19. Hudecova I, Sahota D, Heung MMS, et al. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PLoS One 2014; 9: e88484.
20. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370: 799-808.
21. Chiu RWK, Lo YMD. Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011; 16: 88-93.
22. Lun FMF, Tsui NBY, Chan KCA, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA 2008; 105: 19920-5.
23. Tsui NBY, Kadir RA, Chan KCA, et al. Noninvasive prenatal diagnosis of hemophilia by microfl uidics digital PCR analysis of maternal plasma DNA. Blood 2011; 117: 3684-91.
24. Barrett AN, McDonnell TCR, Chan KCA, et al. Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem 2012; 58: 1026-32.
25. Lo YMD, Chan KCA, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010; 2: 61ra91.
26. Lam KWG, Jiang P, Liao GJW, et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to beta-thalassemia. Clin Chem 2012; 58: 1467-75.
27. New MI, Tong YK, Yuen T, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab 2014: jc20141118.
28. Kitzman JO, Snyder MW, Ventura M, et al. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 2012; 4: 137ra76.
29. Lun FMF, Chiu RWK, Sun K, et al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem 2013; 59: 1583-94.
30. Greely HT. Get ready for the fl ood of fetal gene screening. Nature 2011; 469: 289-91.